HRP20160306T1 - Kombinacija cjepiva i terapijskih sredstava protiv gas - Google Patents
Kombinacija cjepiva i terapijskih sredstava protiv gas Download PDFInfo
- Publication number
- HRP20160306T1 HRP20160306T1 HRP20160306TT HRP20160306T HRP20160306T1 HR P20160306 T1 HRP20160306 T1 HR P20160306T1 HR P20160306T T HRP20160306T T HR P20160306TT HR P20160306 T HRP20160306 T HR P20160306T HR P20160306 T1 HRP20160306 T1 HR P20160306T1
- Authority
- HR
- Croatia
- Prior art keywords
- seq
- protein
- antigen
- preparation according
- mutant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1275—Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9755108P | 2008-09-17 | 2008-09-17 | |
| PCT/IB2009/006949 WO2010076618A1 (en) | 2008-09-17 | 2009-09-17 | Combination gas vaccines and therapeutics |
| EP09786278.3A EP2344523B1 (en) | 2008-09-17 | 2009-09-17 | Combination gas vaccines and therapeutics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160306T1 true HRP20160306T1 (hr) | 2016-04-22 |
Family
ID=41508998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160306TT HRP20160306T1 (hr) | 2008-09-17 | 2009-09-17 | Kombinacija cjepiva i terapijskih sredstava protiv gas |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20100136041A1 (OSRAM) |
| EP (1) | EP2344523B1 (OSRAM) |
| JP (2) | JP5680536B2 (OSRAM) |
| CN (1) | CN102356090B (OSRAM) |
| AU (1) | AU2009334428B2 (OSRAM) |
| BR (1) | BRPI0919236A8 (OSRAM) |
| CA (1) | CA2737453A1 (OSRAM) |
| DK (1) | DK2344523T3 (OSRAM) |
| ES (1) | ES2566740T3 (OSRAM) |
| HR (1) | HRP20160306T1 (OSRAM) |
| HU (1) | HUE027618T2 (OSRAM) |
| MX (1) | MX2011002760A (OSRAM) |
| NZ (1) | NZ591633A (OSRAM) |
| PL (1) | PL2344523T3 (OSRAM) |
| SI (1) | SI2344523T1 (OSRAM) |
| SM (1) | SMT201600125B (OSRAM) |
| WO (1) | WO2010076618A1 (OSRAM) |
| ZA (1) | ZA201102005B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210128D0 (en) * | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| PL2493498T3 (pl) | 2009-10-30 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Oczyszczanie sacharydów otoczkowych staphylococcus aureus typu 5 i typu 8 |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| GB201206366D0 (en) * | 2012-04-11 | 2012-05-23 | Absynth Biologics Ltd | Bacterial vaccine |
| RU2662970C2 (ru) * | 2012-09-18 | 2018-07-31 | Новартис Аг | Везикулы наружной мембраны |
| CN106794236B (zh) | 2014-04-15 | 2021-09-03 | 格里菲斯大学 | A群链球菌疫苗 |
| WO2015169773A2 (en) * | 2014-05-07 | 2015-11-12 | Glaxosmithkline Biologicals S.A. | Mutants of spy0269 |
| US10329601B2 (en) * | 2015-12-28 | 2019-06-25 | Ionian Technologies, Inc. | Nicking and extension amplification reaction (NEAR) of Streptococcus species |
| CN112442472B (zh) * | 2020-11-30 | 2023-05-26 | 四川大学华西医院 | 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法 |
| JP7601913B2 (ja) * | 2021-01-19 | 2024-12-17 | デンカ株式会社 | タンパク質、溶血性連鎖球菌ワクチン、ｄｎａ、ベクター、形質転換体、タンパク質を製造する方法、バキュロウイルス、アグロバクテリウム、ラテックス粒子、キット及び抗ストレプトリジンｏ抗体の測定方法 |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
| CN116875520B (zh) * | 2023-07-12 | 2024-06-14 | 吉林农业大学 | 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用 |
| CN120005039B (zh) * | 2025-01-10 | 2025-12-19 | 遵义医科大学珠海校区 | HtsA-SLOdm融合蛋白及其在制备A族链球菌疫苗中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827038D0 (en) * | 1988-11-18 | 1988-12-21 | Kehoe M | Streptolysin o antigens & uses |
| US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
| JP4875490B2 (ja) * | 2003-07-31 | 2012-02-15 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物 |
| WO2006042027A2 (en) * | 2004-10-08 | 2006-04-20 | Novartis Vaccines And Diagnostics Inc. | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| AU2007348285A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| CA2699513C (en) * | 2007-09-12 | 2018-03-13 | Novartis Ag | Gas57 mutant antigens and gas57 antibodies |
| BRPI0821240B8 (pt) * | 2007-12-21 | 2022-10-04 | Novartis Ag | formas mutantes de estreptolisina o |
-
2009
- 2009-09-17 MX MX2011002760A patent/MX2011002760A/es active IP Right Grant
- 2009-09-17 NZ NZ591633A patent/NZ591633A/xx not_active IP Right Cessation
- 2009-09-17 BR BRPI0919236A patent/BRPI0919236A8/pt not_active Application Discontinuation
- 2009-09-17 EP EP09786278.3A patent/EP2344523B1/en active Active
- 2009-09-17 JP JP2011527423A patent/JP5680536B2/ja active Active
- 2009-09-17 US US12/561,619 patent/US20100136041A1/en not_active Abandoned
- 2009-09-17 PL PL09786278.3T patent/PL2344523T3/pl unknown
- 2009-09-17 ES ES09786278.3T patent/ES2566740T3/es active Active
- 2009-09-17 AU AU2009334428A patent/AU2009334428B2/en active Active
- 2009-09-17 CN CN200980142304.9A patent/CN102356090B/zh active Active
- 2009-09-17 DK DK09786278.3T patent/DK2344523T3/da active
- 2009-09-17 HR HRP20160306TT patent/HRP20160306T1/hr unknown
- 2009-09-17 HU HUE09786278A patent/HUE027618T2/en unknown
- 2009-09-17 SI SI200931421A patent/SI2344523T1/sl unknown
- 2009-09-17 CA CA2737453A patent/CA2737453A1/en not_active Abandoned
- 2009-09-17 WO PCT/IB2009/006949 patent/WO2010076618A1/en not_active Ceased
-
2011
- 2011-03-16 ZA ZA2011/02005A patent/ZA201102005B/en unknown
-
2014
- 2014-11-13 US US14/540,627 patent/US20150132337A1/en not_active Abandoned
- 2014-11-25 JP JP2014237470A patent/JP2015038156A/ja not_active Withdrawn
-
2016
- 2016-04-29 SM SM201600125T patent/SMT201600125B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009334428B2 (en) | 2014-02-20 |
| HUE027618T2 (en) | 2016-11-28 |
| MX2011002760A (es) | 2011-06-16 |
| US20100136041A1 (en) | 2010-06-03 |
| ZA201102005B (en) | 2016-09-28 |
| CA2737453A1 (en) | 2010-07-08 |
| JP2015038156A (ja) | 2015-02-26 |
| US20150132337A1 (en) | 2015-05-14 |
| EP2344523A1 (en) | 2011-07-20 |
| PL2344523T3 (pl) | 2016-09-30 |
| JP2012502969A (ja) | 2012-02-02 |
| BRPI0919236A8 (pt) | 2023-01-31 |
| CN102356090B (zh) | 2016-01-20 |
| NZ591633A (en) | 2012-10-26 |
| SI2344523T1 (sl) | 2016-06-30 |
| JP5680536B2 (ja) | 2015-03-04 |
| SMT201600125B (it) | 2016-07-01 |
| ES2566740T3 (es) | 2016-04-15 |
| BRPI0919236A2 (pt) | 2015-12-15 |
| DK2344523T3 (da) | 2016-04-18 |
| CN102356090A (zh) | 2012-02-15 |
| EP2344523B1 (en) | 2016-02-10 |
| AU2009334428A1 (en) | 2010-07-08 |
| WO2010076618A1 (en) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507500A5 (OSRAM) | ||
| HRP20200727T1 (hr) | Pripravci i metode povezane s varijantama proteina a (spa) | |
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| HRP20160685T1 (hr) | Pripravci koji sadrže pneumokokne antigene | |
| JP2012502969A5 (OSRAM) | ||
| HRP20170094T1 (hr) | Imunogeni pripravak | |
| JP2010011868A5 (OSRAM) | ||
| HRP20141125T1 (hr) | Postupak sprjeäśavanja ili lijeäśenja infekcije bakterijom m. tuberculosis | |
| JP2010508276A5 (OSRAM) | ||
| JP2007528217A (ja) | スタヒロコッカス・アウレウスに対する防御免疫応答を誘導するためのポリペプチド | |
| EP2292646A2 (en) | Small Streptococcus pyogenes antigens and their use | |
| RU2008122435A (ru) | Гибридная и тандемная экспрессия белков нейссерий | |
| RU2013154706A (ru) | Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение | |
| US20100203588A1 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
| US20110020403A1 (en) | immunizing composition | |
| RU2012142305A (ru) | Мутантные антигены gas57 и антитела против gas57 | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| NZ591633A (en) | Combination gas vaccines and therapeutics | |
| JP2008545381A5 (OSRAM) | ||
| WO2007048086A3 (en) | Canine influenza virus and related compositions and methods of use | |
| JP2008500043A (ja) | 黄色ブドウ球菌に対する感染防御免疫応答を誘導するためのポリペプチド | |
| JPH08337598A (ja) | 非型性のヘモフイルス インフルエンザ（Ｈａｅｍｏｐｈｉｌｕｓ ｉｎｆｌｕｅｎｚａｅ）株用のワクチンとしての精製非型性ヘモフイルス インフルエンザＰ５蛋白質 | |
| CN101023186A (zh) | 可诱导针对金黄色葡萄球菌的保护性免疫应答的多肽 | |
| HRP20191864T1 (hr) | Imunogeni pripravci protiv bakterije clostridium difficile | |
| JP2013507116A5 (OSRAM) |